A study of 1.6 million US cancer patients in 2023 found 47.3% had a smoking history, with 14.7% currently smoking at diagnosis. https://ja.ma/4j0u8au
JAMA Oncology
图书期刊出版业
Chicago，Illinois 38,182 位关注者
A member of the JAMA Network, which includes JAMA, 11 specialty journals, and JAMA Network Open.
关于我们
JAMA Oncology is published online weekly, every Thursday, and in 12 print/online issues a year. The journal receives more than 6.4 million annual article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. The journal’s acceptance rate is 13%. The median time to first decision is 2 days, and 50 days with review. The Journal Impact Factor is 28.4, one of the highest ranking among oncology journals. All articles are published online first. Mary L. (Nora) Disis, MD, Director of the UW Institute of Translational Health Science and the Center for Translational Medicine in Women's Health, is the editor in chief.
- 网站
-
https://jamanetwork.com/journals/jamaoncology
JAMA Oncology的外部链接
- 所属行业
- 图书期刊出版业
- 规模
- 5,001-10,000 人
- 总部
- Chicago，Illinois
- 创立
- 2015
- 领域
- Oncology
动态
-
Most viewed in the last 7 days from JAMA Oncology: Survivors of childhood cancer undergo considerable accelerated aging in terms of early onset and excess risk of chronic health conditions. https://ja.ma/3E9bzlv
-
-
This review evaluates different strategies for treating patients with advanced kidney cancer previously exposed to immunotherapy. https://ja.ma/41OkbHm
-
-
For select breast cancer patients with complete response to neoadjuvant systemic therapy, radiotherapy alone without breast surgery may be feasible, as no tumor recurrences were observed at 5-year follow-up. https://ja.ma/4cchQJU
-
-
Interval breast cancer (IntCa) rates remain high despite mammographic screening, highlighting the need for personalized screening based on risk factors like high breast density, hormone replacement therapy, and family history. https://ja.ma/426jo3A
-
-
Routine advanced multidimensional molecular profiling is now required to provide optimal standard of care for patients with CNS tumors. This Review explains the rationale for multidimensional molecular diagnostics for CNS tumors https://ja.ma/4j2xj1f
-
-
Beginning in 2019, fewer patients of inferred African ancestry were found to be eligible for treatment with FDA-approved precision oncology drugs compared with individuals with other inferred genetic ancestries. https://ja.ma/4iQwGIa
-
-
Most viewed in the last 7 days from JAMA Oncology: Cooling and compression were highly effective and significantly reduced the risk of high-grade chemotherapy-induced peripheral neuropathy. https://ja.ma/4icEYdr
-
-
In this nonrandomized clinical trial of patients with early-stage favorable Hodgkin lymphoma treated with minimal up-front conventional chemotherapy, low-risk relapses were salvaged using conventional chemotherapy and involved-field radiotherapy. https://ja.ma/41GxpVl
-
-
A 70-year-old man with a history of hypertension and chronic migraine presented with 10 months of progressive generalized muscle weakness and stiffness. Take the Clinical Challenge. https://ja.ma/4kF0UQ5
-